Atricure Inc. buy stratec
Start price
12.04.19
/
50%
€25.43
Target price
04.11.21
€66.00
Performance (%)
15.17%
End price
05.11.21
€29.29
Summary
This prediction ended on 05.11.21 with a price of €29.29. The prediction had a final performance of 15.17%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Atricure Inc. | -2.857% | -2.857% | -45.161% | -45.161% |
| iShares Core DAX® | 0.869% | 3.389% | 22.351% | 71.506% |
| iShares Nasdaq 100 | -0.852% | -2.157% | 5.543% | 107.710% |
| iShares Nikkei 225® | 0.436% | 1.060% | 13.273% | 46.809% |
| iShares S&P 500 | -0.122% | -0.270% | 3.350% | 65.323% |
Comments by stratec for this prediction
In the thread Atricure Inc. diskutieren
stratec stimmt dem Sentiment von 'Sell' nicht zu
The stock got an Overweight rating with a $37 price target at JP Morgan. Morgan's analyst list three key reasons he likes the shares at current trading levels.
- The valuation is attractive and the name offers durable organic mid-teens top-line growth.
- Has a favorable view on the lack of competitors.
- Sees catalysts from COVERAGE data over the coming 1-year period.
Kursziel geändert auf 46,0
Kursziel geändert auf 66,0
In the thread Trading Atricure Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten